ExLibris header image
SFX Logo
Title: Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease
Source:

Proteomics Clinical Applications [1862-8346] Hu, Yan yr:2007


Collapse list of basic services Basic
Full text
Full text available via Wiley Online Library Full Collection 2019
GO
Full text available via Wiley Online Library STM 2011
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Zhang, J. "Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly." Proteomics - clinical applications 1.8 (2007): 805-819. Link to Full Text for this item Link to SFX for this item
2. Guerreiro, N. "Proteomic 2-D DIGE Profiling of APP23 Transgenic Mice Brain from Pre- plaque and Plaque Phenotypes." Journal of Alzheimer's disease 13.1 (2008): 17-30. Link to SFX for this item
3. Maler, Jens M. "Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: Evidence for novel A beta species." Proteomics 7.20 (2007): 3815-3820. Link to Full Text for this item Link to SFX for this item
4. Lewczuk, P. "Electrophoretic separation of amyloid beta peptides in plasma." Electrophoresis 25.20 (2004): 3336-3343. Link to Full Text for this item Link to SFX for this item
5. Abdi, F.. "Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders." Journal of Alzheimer's disease 9.3 (2006): 293-348. Link to SFX for this item
6. Valensin, G. "fac-{Ru(CO)(3)}(2+) Selectively Targets the Histidine Residues of the beta-Amyloid Peptide 1-28. Implications for New Alzheimer's Disease Treatments Based on Ruthenium Complexes." Inorganic chemistry 49.11 (2010): 4720-4722. Link to Full Text for this item Link to SFX for this item
7. McGuinness, B. "Attention deficits in Alzheimer's disease and vascular dementia." Journal of Neurology, Neurosurgery and Psychiatry 81.2 (2010): 157-159. Link to SFX for this item
8. Sato, T. "Signal peptide peptidase: biochemical properties and modulation by nonsteroidal antiinflammatory drugs." Biochemistry 45.28 (2006): 8649-56. Link to Full Text for this item Link to SFX for this item
9. Longatti, A L. "Choroid plexus and aquaporin-1: a novel explanation of cerebrospinal fluid production." Pediatric neurosurgery 40.6 (2004): 277-83. Link to SFX for this item
10. Schupf, N. "Elevated plasma beta -amyloid peptide Abeta -sub-4-sub-2 levels, incident dementia, and mortality in Down syndrome." Archives of neurology 64.7 (2007): 1007-1013. Link to SFX for this item
11. Man, Shu-Mei M. "Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease." Neurobiology of Aging 28.4 (2007): 485-96. Link to SFX for this item
12. Mollenhauer, B. "Tauopathies and synucleinopathies: Do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?" Journal of neural transmission 114.7 (2007): 919-927. Link to Full Text for this item Link to SFX for this item
13. Zhang, J. "Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases." Journal of Alzheimer's disease 8.4 (2005): 377-386. Link to SFX for this item
14. Bouchard, Rémi W W. "Diagnostic criteria of dementia." The Canadian journal of neurological sciences 34.1 (2007): 11-8. Link to SFX for this item
15. Haque, C. "Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP." Proceedings of the National Academy of Sciences of the United States of America 105.5 (2008): 1716-21. Link to Full Text for this item Link to SFX for this item
16. Youdim, M. "The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti- Parkinson drug, rasagiline." Biochemical Pharmacology 66.8 (2003): 1635-41. Link to SFX for this item
17. Cuchacovich, M. "Tumour necrosis factor (TNF)α - 308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis." Scandinavian journal of rheumatology 35.6 (2006): 435-440. Link to SFX for this item
18. Zhang, J. "Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease." Journal of Alzheimer's disease 7.2 (2005): 125-33. Link to SFX for this item
19. Lawson, B. "Executive functioning in Alzheimer's disease and vascular dementia." International journal of geriatric psychiatry 25.6 (2009): 562-568. Link to Full Text for this item Link to SFX for this item
20. Puchades, M. "Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease." Molecular brain research 118.1 (2003): 140-6. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced